先聲藥業(02096.HK)獲執行董事萬玉山增持7萬股

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

先聲藥業(02096.HK)獲執行董事萬玉山增持7萬股

格隆匯 04-29 08:01

格隆匯APP獲悉，根據聯交所最新權益披露資料顯示，2022年4月25日，先聲藥業(02096.HK)獲執行董事萬玉山在場內以每股均價7.9571港元增持7萬股，涉資約55.7萬港元。

增持後，萬玉山最新持股數目為215.5萬股，持股比例為0.08%。

先聲藥業(02096.HK)

Relevant Stocks

先聲藥業(02096.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

先聲藥業(02096.HK)獲執行董事萬玉山增持7萬股

Services

About Us

Agreement Statement